Literature DB >> 24862385

Infections in status epilepticus: a retrospective 5-year cohort study.

Johan Zelano1, Fredrik Möller2, Judith Dobesberger3, Eugen Trinka3, Eva Kumlien2.   

Abstract

PURPOSE: Status epilepticus (SE) has attracted renewed interest lately, and efforts are made to optimize every treatment stage. For refractory SE, optimal supporting care involves mechanical ventilation and intensive care unit (ICU) admission. Infections often complicate SE and recently a single-centre observational study demonstrated an association between infections and poor short-term outcome of SE in a cohort of severely ill patients. We have here attempted to replicate those findings in a different cohort.
METHOD: We performed a retrospective observational study and included all patients with a diagnosis of SE during 2008-2012 at a Swedish tertiary referral centre.
RESULTS: The cohort consisted of 103 patients (53% female, 47% male, median age 62 years, range 19-87 years). In house mortality was less than 2 and 70% of the patients' were discharged home. The most common aetiologies of SE were uncontrolled epilepsy (37%) and brain tumours (16%). A total of 39 patients suffered infections during their stay. Presence of infection was associated with mechanical ventilation (OR 3.344, 95% CI 1.44-7.79) as well as not being discharged home (OR2.705, 95% CI 1.14-6.44), and duration of SE was significantly longer in patients with infection (median 1 day vs. 2.5 days, p<0.001).
CONCLUSION: We conclude that the previously described association between infections, a longer SE duration, and an unfavourable outcome of SE seems valid also in SE of less severe aetiology.
Copyright © 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ICU; Infection; Status epilepticus

Mesh:

Year:  2014        PMID: 24862385     DOI: 10.1016/j.seizure.2014.04.012

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  8 in total

1.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

2.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study.

Authors:  Raoul Sutter; Gian Marco De Marchis; Saskia Semmlack; Peter Fuhr; Stephan Rüegg; Stephan Marsch; Wendy C Ziai; Peter W Kaplan
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

Review 3.  Healthcare-Associated Infections in the Neurocritical Care Unit.

Authors:  Katharina M Busl
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-27       Impact factor: 5.081

4.  Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?

Authors:  Raoul Sutter
Journal:  CNS Drugs       Date:  2018-10       Impact factor: 5.749

Review 5.  Systemic Complications Following Status Epilepticus.

Authors:  Maximiliano A Hawkes; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-07       Impact factor: 5.081

6.  A Study of Super Refractory Status Epilepticus from India.

Authors:  Usha K Misra; Jayantee Kalita; Deepanshu Dubey
Journal:  Front Neurol       Date:  2017-11-28       Impact factor: 4.003

7.  Procalcitonin and mortality in status epilepticus: an observational cohort study.

Authors:  Raoul Sutter; Martina Valença; Sarah Tschudin-Sutter; Stephan Rüegg; Stephan Marsch
Journal:  Crit Care       Date:  2015-10-09       Impact factor: 9.097

Review 8.  [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology].

Authors:  F Rosenow; J Weber
Journal:  Nervenarzt       Date:  2021-03-22       Impact factor: 1.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.